Literature DB >> 31734709

Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer.

Joost J M van Griethuysen1,2, Doenja M J Lambregts3, Stefano Trebeschi1,2, Max J Lahaye1, Frans C H Bakers4, Roy F A Vliegen5, Geerard L Beets2,6, Hugo J W L Aerts2,7, Regina G H Beets-Tan1,2.   

Abstract

PURPOSE: To compare the performance of advanced radiomics analysis to morphological assessment by expert radiologists to predict a good or complete response to chemoradiotherapy in rectal cancer using baseline staging MRI.
MATERIALS AND METHODS: We retrospectively assessed the primary staging MRIs [prior to chemoradiotherapy (CRT)] of 133 rectal cancer patients from 2 centers. First, two expert radiologists subjectively estimated the likelihood of achieving a "complete response" (ypT0) and "good response" (TRG 1-2), using a 5-point score (based on TN-stage, MRF/EMVI-status, size/signal/shape). Next, tumor volumes were segmented on high b value DWI (semi-automated, corrected by 2 non-expert and 2-expert readers, resulting in 5 segmentations), copied to the remaining sequences after which a total of 2505 radiomic features were extracted from T2W, low and high b value DWI and ADC. Stability of features for noise due to inter-reader and inter-scanner and protocol variations was assessed using intraclass correlation (ICC) and the Kruskal-Wallis test. Using data from center 1 (n = 86; training set), top 9 features were selected using minimum Redundancy Maximum Relevance and combined in a logistic regression model. Finally, diagnostic performance of the fitted models was assessed on data from center 2 (n = 47; validation set) and compared to the performance of the radiologists.
RESULTS: The Radiomic models resulted in AUCs of 0.69-0.79 (with similar results for the segmentations performed by expert/non-expert readers) to predict response, results similar to the morphologic prediction by the expert radiologists (AUC 0.67-0.83). Radiomics using semi-automatically generated segmentations (without manual input) did not result in significant predictive performance.
CONCLUSIONS: Radiomics could predict response to therapy with comparable diagnostic performance as expert radiologists, regardless of whether image segmentation was performed by non-expert or expert readers, indicating that expert input is not required in order for the radiomics workflow to produce significant predictive performance.

Entities:  

Keywords:  Magnetic resonance imaging; Radiomics; Rectal cancer; Response prediction; Texture analysis

Mesh:

Year:  2020        PMID: 31734709     DOI: 10.1007/s00261-019-02321-8

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  12 in total

1.  Benchmarking Various Radiomic Toolkit Features While Applying the Image Biomarker Standardization Initiative toward Clinical Translation of Radiomic Analysis.

Authors:  Mingxi Lei; Bino Varghese; Darryl Hwang; Steven Cen; Xiaomeng Lei; Bhushan Desai; Afshin Azadikhah; Assad Oberai; Vinay Duddalwar
Journal:  J Digit Imaging       Date:  2021-09-20       Impact factor: 4.903

2.  Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models.

Authors:  Iram Shahzadi; Alex Zwanenburg; Annika Lattermann; Annett Linge; Christian Baldus; Jan C Peeken; Stephanie E Combs; Markus Diefenhardt; Claus Rödel; Simon Kirste; Anca-Ligia Grosu; Michael Baumann; Mechthild Krause; Esther G C Troost; Steffen Löck
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

Review 3.  Rectal MRI radiomics for predicting pathological complete response: Where we are.

Authors:  Joao Miranda; Gary Xia Vern Tan; Maria Clara Fernandes; Onur Yildirim; John A Sims; Jose de Arimateia Batista Araujo-Filho; Felipe Augusto de M Machado; Antonildes N Assuncao-Jr; Cesar Higa Nomura; Natally Horvat
Journal:  Clin Imaging       Date:  2021-11-16       Impact factor: 2.420

4.  A Nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.

Authors:  Wei Jiang; Min Li; Jie Tan; Mingyuan Feng; Jixiang Zheng; Dexin Chen; Zhangyuanzhu Liu; Botao Yan; Guangxing Wang; Shuoyu Xu; Weiwei Xiao; Yuanhong Gao; Shuangmu Zhuo; Jun Yan
Journal:  Ann Surg Oncol       Date:  2021-06-19       Impact factor: 5.344

5.  MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer.

Authors:  Maxiaowei Song; Shuai Li; Hongzhi Wang; Ke Hu; Fengwei Wang; Huajing Teng; Zhi Wang; Jin Liu; Angela Y Jia; Yong Cai; Yongheng Li; Xianggao Zhu; Jianhao Geng; Yangzi Zhang; XiangBo Wan; Weihu Wang
Journal:  Br J Cancer       Date:  2022-04-02       Impact factor: 9.075

6.  Classification of retinoblastoma-1 gene mutation with machine learning-based models in bladder cancer.

Authors:  Okan İnce; Hülya Yıldız; Tanju Kisbet; Şükrü Mehmet Ertürk; Hakan Önder
Journal:  Heliyon       Date:  2022-04-21

Review 7.  MRI Evaluation of Complete Response of Locally Advanced Rectal Cancer After Neoadjuvant Therapy: Current Status and Future Trends.

Authors:  Qiaoyu Xu; Yanyan Xu; Hongliang Sun; Tao Jiang; Sheng Xie; Bee Yen Ooi; Yi Ding
Journal:  Cancer Manag Res       Date:  2021-06-01       Impact factor: 3.989

Review 8.  Emerging applications of radiomics in rectal cancer: State of the art and future perspectives.

Authors:  Min Hou; Ji-Hong Sun
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

9.  A Deep Learning Model to Predict the Response to Neoadjuvant Chemoradiotherapy by the Pretreatment Apparent Diffusion Coefficient Images of Locally Advanced Rectal Cancer.

Authors:  Hai-Tao Zhu; Xiao-Yan Zhang; Yan-Jie Shi; Xiao-Ting Li; Ying-Shi Sun
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

10.  MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer.

Authors:  Andrea Delli Pizzi; Antonio Maria Chiarelli; Piero Chiacchiaretta; Martina d'Annibale; Pierpaolo Croce; Consuelo Rosa; Domenico Mastrodicasa; Stefano Trebeschi; Doenja Marina Johanna Lambregts; Daniele Caposiena; Francesco Lorenzo Serafini; Raffaella Basilico; Giulio Cocco; Pierluigi Di Sebastiano; Sebastiano Cinalli; Antonio Ferretti; Richard Geoffrey Wise; Domenico Genovesi; Regina G H Beets-Tan; Massimo Caulo
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.